2,066 reports of this reaction
2.8% of all TORSEMIDE reports
#2 most reported adverse reaction
FATIGUE is the #2 most commonly reported adverse reaction for TORSEMIDE, manufactured by Sarfez Pharmaceuticals Inc. There are 2,066 FDA adverse event reports linking TORSEMIDE to FATIGUE. This represents approximately 2.8% of all 74,224 adverse event reports for this drug.
TORSEMIDE has an overall safety score of 85 out of 100. Patients taking TORSEMIDE who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for TORSEMIDE, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for TORSEMIDE:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 2,066 FDA reports for TORSEMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 2.8% of all adverse event reports for TORSEMIDE, making it one of the most commonly reported side effect.
If you experience fatigue while taking TORSEMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.